Comment on Andersen et al, pancreatitis-diabetes-pancreatic cancer: summary of an NIDDK-NCI workshop.
Global Chief Medical Office, Research & Development, Novo Nordisk A/S, Bagsværd Denmark Diabetes Research Unit, Research & Development, Novo Nordisk A/S, Måløv Denmark Global Medical Affairs GLP-1 Diabetes, Novo Nordisk A/S, Denmark cbsv@novonordisk.com.
Alan Charles
AC
Moses
Lotte Bjerre
LB
Knudsen
Claus Bo
CB
Svendsen
D021441:Carcinoma, Pancreatic Ductal / Q000517:prevention & control*; D003920:Diabetes Mellitus / Q000628:therapy*; D006801:Humans; D010190:Pancreatic Neoplasms / Q000517:prevention & control*; D050500:Pancreatitis, Chronic / Q000628:therapy*